NCT03767335
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03767335
Title MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer (B-PRECISE-01)
Acronym B-PRECISE-01
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Menarini Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | BEL

Facility Status City State Zip Country Details
Holy Cross Hospital Inc. Fort Lauderdale Florida 33308 United States Details
Detroit Clinical Research Center Farmington Hills Michigan 48334 United States Details
Washington University St Louis Missouri 63130 United States Details
Cliniques Universitaires Saint-Luc Brussels Belgium Details
Institut Jules Bordet Brussels Belgium Details
UZ Leuven Leuven Belgium Details
Centre Georges François Leclerc Dijon France Details
Centre Oscar Lambret Lille France Details
Institut Régional du Cancer de Montpellier Montferrier-sur-Lez France Details
ICO - Site René Gauducheau Saint-Herblain France Details
Institut Claudius Regaud Oncopole Toulouse France Details
Institut Gustave Roussy Villejuif France Details
Azienda Ospedaliero Universitaria Mater Domini Catanzaro Italy Details
Istituto Clinico Humanitas Milan Italy Details
Istituto Europeo di Oncologia (IEO) Milan Italy Details
Ospedale San Raffaele Milan Italy Details
Hospital Clínic i Provincial de Barcelona Barcelona Spain Details
Hospital Universitari Vall d'Hebron Barcelona Spain Details
Centro Integral Oncologico Clara Campal Madrid Spain Details
Hospital General Universitario Gregorio Marañon Madrid Spain Details
START Madrid Fundacion Jimenez Diaz Madrid Spain Details
Hospital Clínico Universitario Virgen de la Victoria Málaga Spain Details
Hospital Universitario Virgen del Rocío Seville Spain Details
Velindre Cancer Centre Cardiff United Kingdom Details
Sarah Cannon Research Institute UK London United Kingdom Details
University College London Hospitals London United Kingdom Details
The Christie Manchester United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field